Report Detail
Global Non-oncology Biopharmaceuticals Market Growth (Status and Outlook) 2019-2024
- RnM3411885 |
- 13 May, 2019 |
- Global |
- 157 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial. This report studies Non-oncology biopharmaceutical which are the drugs that are used in the treatment of various diseases rather than cancer.
According to this study, over the next five years the Non-oncology Biopharmaceuticals market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Non-oncology Biopharmaceuticals business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Non-oncology Biopharmaceuticals market by product type, application, key companies and key regions.
This study considers the Non-oncology Biopharmaceuticals value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Biologics
Biosimilars
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Immunology
Endocrinology
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
Sanofi
Johnson & Johnson
Pfizer
Novo Nordisk
Novartis
Merck
Teva
Eli Lilly
Bristol-Myers Squibb
GlaxoSmithKline
UCB Pharma
Amgen
AbbVie
Takeda
AstraZeneca
Mylan
LEO Pharma
Boehringer Ingelheim
Alexion Pharmaceuticals
Elusys Therapeutics
Swedish Orphan Biovitrum
Biogen
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Non-oncology Biopharmaceuticals market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Non-oncology Biopharmaceuticals market by identifying its various subsegments.
Focuses on the key global Non-oncology Biopharmaceuticals players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Non-oncology Biopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Non-oncology Biopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Non-oncology Biopharmaceuticals Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Non-oncology Biopharmaceuticals Market Size 2014-2024
- 2.1.2 Non-oncology Biopharmaceuticals Market Size CAGR by Region
- 2.2 Non-oncology Biopharmaceuticals Segment by Type
- 2.2.1 Biologics
- 2.2.2 Biosimilars
- 2.3 Non-oncology Biopharmaceuticals Market Size by Type
- 2.3.1 Global Non-oncology Biopharmaceuticals Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Non-oncology Biopharmaceuticals Market Size Growth Rate by Type (2014-2019)
- 2.4 Non-oncology Biopharmaceuticals Segment by Application
- 2.4.1 Immunology
- 2.4.2 Endocrinology
- 2.4.3 Others
- 2.5 Non-oncology Biopharmaceuticals Market Size by Application
- 2.5.1 Global Non-oncology Biopharmaceuticals Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Non-oncology Biopharmaceuticals Market Size Growth Rate by Application (2014-2019)
3 Global Non-oncology Biopharmaceuticals by Players
- 3.1 Global Non-oncology Biopharmaceuticals Market Size Market Share by Players
- 3.1.1 Global Non-oncology Biopharmaceuticals Market Size by Players (2017-2019)
- 3.1.2 Global Non-oncology Biopharmaceuticals Market Size Market Share by Players (2017-2019)
- 3.2 Global Non-oncology Biopharmaceuticals Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Non-oncology Biopharmaceuticals by Regions
- 4.1 Non-oncology Biopharmaceuticals Market Size by Regions
- 4.2 Americas Non-oncology Biopharmaceuticals Market Size Growth
- 4.3 APAC Non-oncology Biopharmaceuticals Market Size Growth
- 4.4 Europe Non-oncology Biopharmaceuticals Market Size Growth
- 4.5 Middle East & Africa Non-oncology Biopharmaceuticals Market Size Growth
5 Americas
- 5.1 Americas Non-oncology Biopharmaceuticals Market Size by Countries
- 5.2 Americas Non-oncology Biopharmaceuticals Market Size by Type
- 5.3 Americas Non-oncology Biopharmaceuticals Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Non-oncology Biopharmaceuticals Market Size by Countries
- 6.2 APAC Non-oncology Biopharmaceuticals Market Size by Type
- 6.3 APAC Non-oncology Biopharmaceuticals Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Non-oncology Biopharmaceuticals by Countries
- 7.2 Europe Non-oncology Biopharmaceuticals Market Size by Type
- 7.3 Europe Non-oncology Biopharmaceuticals Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Non-oncology Biopharmaceuticals by Countries
- 8.2 Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Type
- 8.3 Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Non-oncology Biopharmaceuticals Market Forecast
- 10.1 Global Non-oncology Biopharmaceuticals Market Size Forecast (2019-2024)
- 10.2 Global Non-oncology Biopharmaceuticals Forecast by Regions
- 10.2.1 Global Non-oncology Biopharmaceuticals Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Non-oncology Biopharmaceuticals Forecast by Type
- 10.8 Global Non-oncology Biopharmaceuticals Forecast by Application
11 Key Players Analysis
- 11.1 Roche
- 11.1.1 Company Details
- 11.1.2 Non-oncology Biopharmaceuticals Product Offered
- 11.1.3 Roche Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Roche News
- 11.2 Sanofi
- 11.2.1 Company Details
- 11.2.2 Non-oncology Biopharmaceuticals Product Offered
- 11.2.3 Sanofi Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Sanofi News
- 11.3 Johnson & Johnson
- 11.3.1 Company Details
- 11.3.2 Non-oncology Biopharmaceuticals Product Offered
- 11.3.3 Johnson & Johnson Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Johnson & Johnson News
- 11.4 Pfizer
- 11.4.1 Company Details
- 11.4.2 Non-oncology Biopharmaceuticals Product Offered
- 11.4.3 Pfizer Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Pfizer News
- 11.5 Novo Nordisk
- 11.5.1 Company Details
- 11.5.2 Non-oncology Biopharmaceuticals Product Offered
- 11.5.3 Novo Nordisk Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Novo Nordisk News
- 11.6 Novartis
- 11.6.1 Company Details
- 11.6.2 Non-oncology Biopharmaceuticals Product Offered
- 11.6.3 Novartis Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Novartis News
- 11.7 Merck
- 11.7.1 Company Details
- 11.7.2 Non-oncology Biopharmaceuticals Product Offered
- 11.7.3 Merck Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Merck News
- 11.8 Teva
- 11.8.1 Company Details
- 11.8.2 Non-oncology Biopharmaceuticals Product Offered
- 11.8.3 Teva Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Teva News
- 11.9 Eli Lilly
- 11.9.1 Company Details
- 11.9.2 Non-oncology Biopharmaceuticals Product Offered
- 11.9.3 Eli Lilly Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Eli Lilly News
- 11.10 Bristol-Myers Squibb
- 11.10.1 Company Details
- 11.10.2 Non-oncology Biopharmaceuticals Product Offered
- 11.10.3 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Bristol-Myers Squibb News
- 11.11 GlaxoSmithKline
- 11.12 UCB Pharma
- 11.13 Amgen
- 11.14 AbbVie
- 11.15 Takeda
- 11.16 AstraZeneca
- 11.17 Mylan
- 11.18 LEO Pharma
- 11.19 Boehringer Ingelheim
- 11.20 Alexion Pharmaceuticals
- 11.21 Elusys Therapeutics
- 11.22 Swedish Orphan Biovitrum
- 11.23 Biogen
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Non-oncology Biopharmaceuticals . Industry analysis & Market Report on Non-oncology Biopharmaceuticals is a syndicated market report, published as Global Non-oncology Biopharmaceuticals Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Non-oncology Biopharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
